By Stephen Nakrosis LumiraDx said Friday it will sell certain companies related to its point-of-care technology to Roche. Andrew Johnson, Lisa Rickelton and.
By Emon Reiser Shares of Silo Pharma declined after the developmental-stage biopharmaceutical company said its partner received regulatory approval to begin.
By Colin Kellaher Shares of Bluejay Diagnostics tumbled nearly 35% in premarket trading Thursday after the medical-technology company said it was raising.